Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Processa Pharmaceuticals, Inc. (PCSA)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K/A | 10-K | 10-K |
| Revenues | | | | | | 100.0% | | 100.0% |
| Cost of goods sold | | | | | | 43141.4% | | 62.3% |
| Gross profit | | | | | | -43041.4% | | 37.7% |
| Selling, general and administrative | | | | | | 0.0% | | 1883.5% |
| Research and development | | | | | | | | 166.1% |
| General and administrative | | | | | | 0.0% | | |
| EBITDA | | | | | | -43110.4% | | -3804.4% |
| Depreciation | | | | | | 31.0% | | 66.2% |
| EBITA | | | | | | -43141.4% | | -3870.7% |
| Amortization of intangibles | | | | | | | | 333.0% |
| EBIT | | | | | | -43141.4% | | -4203.7% |
| Pre-tax income | | | | | | -43041.4% | | -3436.7% |
| Income taxes | | | | | | 0.0% | | 0.1% |
| Net income | | | | | | -43041.4% | | -5622.2% |
|